These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 29221779

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.
    George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C, Zheng Y.
    Sleep Med; 2010 Jan; 11(1):38-42. PubMed ID: 19897413
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sleep-stage sequencing of sleep-onset REM periods in MSLT predicts treatment response in patients with narcolepsy.
    Drakatos P, Patel K, Thakrar C, Williams AJ, Kent BD, Leschziner GD.
    J Sleep Res; 2016 Apr; 25(2):203-10. PubMed ID: 26541241
    [Abstract] [Full Text] [Related]

  • 25. Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) Trial.
    Roth T, Morse AM, Bogan R, Roy A, Gudeman J, Dauvilliers Y.
    Clin Ther; 2024 Oct; 46(10):791-798. PubMed ID: 39153911
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.
    Dauvilliers Y, Roth T, Bogan R, Thorpy MJ, Morse AM, Roy A, Gudeman J.
    Sleep Med; 2024 Dec; 124():209-216. PubMed ID: 39321628
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
    Lecendreux M, Plazzi G, Dauvilliers Y, Rosen CL, Ruoff C, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    J Clin Sleep Med; 2022 Sep 01; 18(9):2217-2227. PubMed ID: 35689598
    [Abstract] [Full Text] [Related]

  • 40. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK, Roth T, Schwartz J, Miloslavsky M.
    J Clin Sleep Med; 2015 Apr 15; 11(4):427-32. PubMed ID: 25580605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.